Hal Kennedy
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 9
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism 2
- Surgery top 5%
- Lipoproteins and Cardiovascular Health 8
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 3
-
- Drug Transport and Resistance Mechanisms 2
-
- Alzheimer's disease research and treatments 2
-
- Computational Drug Discovery Methods 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Santica M. MarcovinaJohn J. AlbersS MarcovinaJ J AlbersW. Harry HannonL. Omar HendersonEllen M. WijsmanN.H. Chapman
- Journals
- Journal of Lipid Research (6 papers)Clinical Chemistry (3 papers)Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2 papers)
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Hal Kennedy
21 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 79
- Endocrinology, Diabetes and Metabolism 613
- Cancer Research 320
- Surgery 886
- Cardiology and Cardiovascular Medicine 290
- Immunology 118
Countries citing papers authored by Hal Kennedy
This map shows the geographic impact of Hal Kennedy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hal Kennedy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hal Kennedy more than expected).
Fields of papers citing papers by Hal Kennedy
This network shows the impact of papers produced by Hal Kennedy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hal Kennedy. The network helps show where Hal Kennedy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hal Kennedy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 17 | |
| 2 | 2011 | 14 | |
| 3 | 2011 | 73 | |
| 4 | 2010 | 30 | |
| 5 | 2010 | 5 | |
| 6 | 2008 | 11 | |
| 7 | 2005 | 43 | |
| 8 | 2002 | 30 | |
| 9 | 2002 | 32 | |
| 10 | 2002 | 26 | |
| 11 | 2001 | 18 | |
| 12 | 2000 | 241 | |
| 13 | 1999 | 13 | |
| 14 | 1999 | 43 | |
| 15 | 1999 | 40 | |
| 16 | 1996 | 196 | |
| 17 | 1996 | 66 | |
| 18 | 1995 | 55 | |
| 19 | 1992 | 94 | |
| 20 | 1988 | 40 |
About Hal Kennedy
Hal Kennedy is a scholar working on Endocrinology, Diabetes and Metabolism, Internal Medicine, Statistics and Probability, Cancer Research and Surgery, having authored 21 papers that have together received 1.3k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (9 papers), Lipoproteins and Cardiovascular Health (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Drug Transport and Resistance Mechanisms (2 papers), Alzheimer's disease research and treatments (2 papers), Computational Drug Discovery Methods (2 papers), Liver Disease Diagnosis and Treatment (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (613 citations), Cancer Research (320 citations), Surgery (886 citations), Cardiology and Cardiovascular Medicine (290 citations) and Immunology (118 citations). Hal Kennedy has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Santica M. Marcovina, John J. Albers, S Marcovina, J J Albers, J J Albers, W. Harry Hannon, L. Omar Henderson, Ellen M. Wijsman, N.H. Chapman and Marian C. Cheung. Their work appears in journals such as Journal of Lipid Research, Clinical Chemistry, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, Clinica Chimica Acta and Multiple Sclerosis and Related Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.